Institutional Ownership Lineage Cell Therapeutics, Inc. (LCTX)
This table provides information about the institutional ownership of Lineage Cell Therapeutics, Inc. (LCTX). We have compiled data on the 142 institutions that hold shares in the stock, with a total of 106 Million shares, which have been reported (via 13F filing form) to have a value of $132 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Broadwood Capital Inc
New York, NY |
Aug 13, 2025 Q2 2025 |
49,560,992
shares
|
$61.5 Million
2.94% of portfolio
|
Q1 2025
Added 18.95%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
9,559,466
shares
|
$11.9 Million
0.0% of portfolio
|
Q2 2024
Added 12.54%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
8,482,873
shares
|
$10.5 Million
0.0% of portfolio
|
Q2 2025
Reduced 4.89%
|
|
|
Defender Capital, Llc.
|
Jul 25, 2025 Q2 2025 |
6,785,177
shares
|
$8.41 Million
2.42% of portfolio
|
Q2 2025
Added 7.52%
|
|
|
Raffles Associates LP
New York, NY |
Aug 15, 2025 Q2 2025 |
5,392,088
shares
|
$6.69 Million
6.02% of portfolio
|
Q2 2025
Reduced 4.43%
|
|
|
Comerica Bank
|
Aug 13, 2025 Q2 2025 |
4,600,000
shares
|
$5.7 Million
0.02% of portfolio
|
Q2 2025
Added 53.33%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
2,600,577
shares
|
$3.22 Million
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
2,431,619
shares
|
$3.02 Million
0.0% of portfolio
|
Q2 2025
Reduced 45.79%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
1,972,335
shares
|
$2.45 Million
0.0% of portfolio
|
Q2 2025
Reduced 13.92%
|
|
|
Jane Street Group, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
1,506,396
shares
|
$1.87 Million
0.0% of portfolio
|
Q2 2025
Added 2113.08%
|
|
|
Dauntless Investment Group, LLC
Commerce Township, MI |
Aug 14, 2025 Q2 2025 |
1,205,930
shares
|
$1.5 Million
1.94% of portfolio
|
Q2 2025
New holding
|
|
|
Gsa Capital Partners LLP
London, X0 |
Jul 22, 2025 Q2 2025 |
897,611
shares
|
$1.11 Million
0.06% of portfolio
|
Q2 2025
Reduced 4.19%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
849,522
shares
|
$1.05 Million
0.0% of portfolio
|
Q2 2025
Reduced 67.94%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
837,463
shares
|
$1.04 Million
0.0% of portfolio
|
Q2 2025
Reduced 13.55%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
605,044
shares
|
$750,254
0.0% of portfolio
|
Q1 2025
Reduced 36.07%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Aug 14, 2025 Q2 2025 |
547,242
shares
|
$678,580
0.0% of portfolio
|
Q2 2025
Added 131.78%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
515,445
shares
|
$639,151
0.0% of portfolio
|
Q2 2023
New holding
|
|
|
Squarepoint Ops LLC
New York, NY |
Aug 27, 2025 Q2 2025 |
511,107
shares
|
$633,772
0.0% of portfolio
|
Q2 2025
Added 42.86%
|
|
|
Northern Trust Corp
Chicago, IL |
Aug 13, 2025 Q2 2025 |
510,462
shares
|
$632,972
0.0% of portfolio
|
Q2 2025
Reduced 66.84%
|
|
|
Red Crane Wealth Management, LLC
San Francisco, CA |
Jul 30, 2025 Q2 2025 |
495,998
shares
|
$615,037
0.41% of portfolio
|
Q2 2025
Added 0.0%
|
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
Aug 14, 2025 Q2 2025 |
435,259
shares
|
$539,721
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Y Intercept (Hong Kong) LTD
|
Aug 01, 2025 Q2 2025 |
405,043
shares
|
$502,253
0.01% of portfolio
|
Q2 2025
New holding
|
|
|
ETF Managers Group, LLC
Summit, NJ |
Apr 17, 2023 Q1 2023 |
318,596
shares
|
$395,059
0.02% of portfolio
|
Q1 2023
Reduced 10.0%
|
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
317,977
shares
|
$394,291
0.0% of portfolio
|
Q2 2025
Reduced 33.81%
|
|
|
Brevan Howard Capital Management LP
St. Helier, Y9 |
Aug 14, 2025 Q2 2025 |
308,877
shares
|
$383,007
0.0% of portfolio
|
Q2 2025
New holding
|